Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Linda, Gritz"'
Autor:
Jim Witek, Christoph Sarrazin, Donghan Luo, Leif Bengtsson, I. Dierynck, N. Adda, Tara L. Kieffer, Robert S. Kauffman, Linda Gritz, Gaston Picchio, Douglas J. Bartels, Sandra De Meyer, Anne Ghys
Publikováno v:
Journal of Clinical Virology. 59:148-155
Background Telaprevir-based therapy is associated with rapid decline in HCV RNA, enabling the application of early futility rules. Objectives To familiarize physicians with this paradigm, a comprehensive analysis of the most frequent HCV viral load p
Autor:
Kimberly A. Zinnack, Norman L. Letvin, Kristin Beaudry, Alicia Gómez Yafal, Petr O. Ilyinskii, Dennis Panicali, Kelledy Manson, Shawn S. Jackson, Valerie Philippon, Marcelo J. Kuroda, Linda Gritz, Michelle A. Lifton, Gail P. Mazzara
Publikováno v:
Journal of Virology. 79:6554-6559
Poxvirus vaccine vectors, although capable of eliciting potent immune responses, pose serious health risks in immunosuppressed individuals. We therefore constructed five novel recombinant vaccinia virus vectors which contained overlapping deletions o
Autor:
Gaston Picchio, Leif Bengtsson, Tara L. Kieffer, Nathalie Adda, Linda Gritz, Ira M. Jacobson, Doug J. Bartels, Robert S. Kauffman, Frank Tomaka, Don Luo
Publikováno v:
Clinical Gastroenterology and Hepatology. 11:193-195
For patients treated with telaprevir, peginterferon, and ribavirin, futility rules have been developed to prevent needless drug exposure and minimize development of drug-resistant variants for patients who have little or no chance of achieving a sust
Autor:
Herman F. Staats, Alicia Gómez Yafal, Sushila K. Nordone, Norman L. Letvin, Barton F. Haynes, Hua-Xin Liao, Shawn S. Jackson, James W. Peacock, Linda Gritz, Gail P. Mazzara
Publikováno v:
Journal of Virology. 78:13163-13172
Induction of mucosal anti-human immunodeficiency virus type 1 (HIV-1) T-cell responses in males and females will be important for the development of a successful HIV-1 vaccine. An HIV-1 envelope peptide, DNA plasmid, and recombinant modified vaccinia
Publikováno v:
Cellular Immunology. 222:45-57
The role of OX40L on the activation of T cells was investigated using poxvirus vectors expressing OX40L alone or in combination with three other T-cell costimulatory molecules: B7-1, ICAM-1, and LFA-3. Poxvirus vector-infected cells were used to stim
Autor:
Dennis Panicali, Claude P. Genain, Norman L. Letvin, Narendra Joshi, John N. Whitaker, Richard L. Davis, Stephen L. Hauser, Linda Gritz
Publikováno v:
Journal of Neuroimmunology. 79:119-128
A primary demyelinating form of experimental allergic encephalomyelitis (EAE) resembling human multiple sclerosis (MS) occurs in Callithrix jacchus marmosets following immunization with human white matter. Participation of a T-cell immune response ag
Autor:
Joseph E. Tomaszewski, Linda Gritz, Jeffrey Schlom, Judy Kantor, Clyde W Wheeler, Susan J. Donohue, Barry S. Levine, James W. Hodge, Dennis Panicali
Publikováno v:
International Journal of Cancer. 63:231-237
Prostate-specific antigen (PSA) is a serine protease secreted by prostatic epithelial cells and is widely used as a marker for prostate cancer. The tissue specificity of PSA makes it a potential target for active specific immunotherapy, especially in
Autor:
Leif Bengtsson, Frank Tomaka, Christoph Sarrazin, Tara L. Kieffer, I. Dierynck, S. De Meyer, G. Picchio, Robert S. Kauffman, Anne Ghys, N. Adda, Linda Gritz, Donghan Luo, Douglas J. Bartels
Publikováno v:
Zeitschrift für Gastroenterologie. 50
Autor:
Dennis Panicali, Lawrence Kenneth Cohen, Linda Gritz, Carolyn H. Fedor, Elizabeth M. O'neill, Sharon Jenkins
Publikováno v:
AIDS Research and Human Retroviruses. 7:991-998
Recombinant fowlpox viruses (FPV) containing the env or gag-pol genes of simian immunodeficiency virus from macaques (SIVmac) were constructed. The env, gag, and pol-encoded polypeptides were efficiently expressed and processed in avian cells product
Autor:
Nicholas P. Restifo, Suzanne L. Topalian, Leah R. Haworth, Linda Rogers-Freezer, Richard M. Sherry, Sharon Mavroukakis, Dennis Panicali, Andrea Abati, Steven A. Rosenberg, Kimberly R. Lindsey, Lisa C. Goldfeder, Kimberly A. Zinnack, Donald E. White, Linda Gritz, Monica Gonzales, Patricia Fetsch, Seth M. Steinberg
Purpose: Two clinical trials were conducted to evaluate the clinical efficacy and immunologic impact of vaccination against the tyrosinase protein plus systemic interleukin 2 (IL-2) administration in patients with advanced metastatic melanoma.Experim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db79bb43bb1101f453c73cb5853d23cc
https://europepmc.org/articles/PMC2151202/
https://europepmc.org/articles/PMC2151202/